Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian S Ray

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Bioorganic & Medicinal Chemistry|April 23, 2010
Discovery of GS-9131: Design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148Richard L Mackman, Adrian S Ray, Hon C Hui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 30, 2018
Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic SteatohepatitisEric J Lawitz, Angie Coste, Fred Poordad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphomaHans Reiser, Jianying Wang, Lee Chong, et al.
Journal of Medicinal Chemistry|April 4, 2013
Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patientsAesop Cho, Lijun Zhang, Jie Xu, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2014
Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrugJoy Y Feng, Guofeng Cheng, Jason Perry, et al.
Science Translational Medicine|June 30, 2017
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronavirusesTimothy P Sheahan, Amy C Sims, Rachel L Graham, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical StudiesSarah-Eve Lemay, Monica S Montesinos, Yann Grobs, et al.
Circulation|January 20, 2025
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah-Eve Lemay, Mónica S Montesinos, Yann Grobs, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2017
Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable propertiesThorsten A Kirschberg, Sammy Metobo, Michael O Clarke, et al.
Journal of Medicinal Chemistry|January 27, 2017
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging VirusesDustin Siegel, Hon C Hui, Edward Doerffler, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry|April 23, 2010
Discovery of GS-9131: Design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148Richard L Mackman, Adrian S Ray, Hon C Hui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 30, 2018
Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic SteatohepatitisEric J Lawitz, Angie Coste, Fred Poordad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphomaHans Reiser, Jianying Wang, Lee Chong, et al.
Journal of Medicinal Chemistry|April 4, 2013
Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patientsAesop Cho, Lijun Zhang, Jie Xu, et al.
Antimicrobial Agents and Chemotherapy|January 15, 2014
Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrugJoy Y Feng, Guofeng Cheng, Jason Perry, et al.
Science Translational Medicine|June 30, 2017
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronavirusesTimothy P Sheahan, Amy C Sims, Rachel L Graham, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical StudiesSarah-Eve Lemay, Monica S Montesinos, Yann Grobs, et al.
Circulation|January 20, 2025
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah-Eve Lemay, Mónica S Montesinos, Yann Grobs, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2017
Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable propertiesThorsten A Kirschberg, Sammy Metobo, Michael O Clarke, et al.
Journal of Medicinal Chemistry|January 27, 2017
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging VirusesDustin Siegel, Hon C Hui, Edward Doerffler, et al.
Pageof 11